News und Analysen
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced record-setting attendance and
DGAP-News: Vita 34 introduces new Chief Financial Officer at the Annual General Meeting
COLTENE announces 2022 half-year results and outlook
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its Cognigen division worked
MD Medical Group Investments Plc: MD Medical Group opens new medical centre in Moscow
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the third quarter of fiscal year 2022, the period ended May 31, 2022, after the close of the
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has published important
DGAP-News: MicroVision to Showcase its Automotive Lidar Sensor at ADAS & Automotive Technology Expo in Stuttgart, Germany
NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today the commercial unveiling of its new AtoMx™ Spatial
NanoString to Unveil New Platforms and Showcase Spatial Biology Research at 2022 Advances in Genome Biology and Technology (AGBT) General Meeting
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced plans to commercially unveil the CosMx™ Spatial
DGAP-News: Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter
DGAP-News: MeVis Medical Solutions AG: MeVis publishes figures for the first half of fiscal year 2021/2022
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the release of version 10.4 (X.4)
Quotient Appoints Kimberly Anstett to its Board of Directors
Quotient Technology Inc. (NYSE: QUOT) (“Quotient” or the “Company”), the leading digital media and promotions technology company, today announced that it has appointed Kimberly Anstett to the
NanoString Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a seamless, cloud-based workflow that improves the
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
DGAP-News: Eckert & Ziegler with Sales Growth in the First Quarter of 2022
Geratherm Medical AG: Voluntary delisting offer by JotWe GmbH published
DGAP-News: Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Alpha Radioisotopes
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that the U.S. Food and Drug
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the
DGAP-News: M1 Kliniken AG: Supervisory Board adopts (consolidated) financial statements 2021 of M1 Kliniken AG. No deviations from the preliminary figures for financial year 2021 published at the end of March
DGAP-News: MediClin AG: Group sales for the 1st quarter of 2022 significantly above the previous year's figure
DGAP-News: Vita 34 AG: Special items reflected in significant decline in earnings despite operational success in fiscal 2021
DGAP-Adhoc: Vita 34 publishes revenue and earnings forecast for the 2022 financial year